Literature DB >> 1377286

Effects of hypertonic saline dextran resuscitation on oxygen delivery, oxygen consumption, and lipid peroxidation after burn injury.

R Tokyay1, S T Zeigler, G C Kramer, C S Rogers, J P Heggers, D L Traber, D N Herndon.   

Abstract

We compared the effects of lactated Ringer's (LR) and hypertonic saline dextran (HSD) on postburn cardiovascular function, O2 consumption, lipid peroxidation, and bacterial translocation. Miniature pigs with 40% total body surface area (TBSA), third-degree burns received, 30 minutes postburn, either Parkland resuscitation (LR group, n = 8) or HSD, 10 mL/kg/30 minutes, followed by LR, 4 mL/kg/%burn over the next 23 hours (HSD group, n = 8). The HSD prevented the early decrease in cardiac index (CI); the early increase in the resistance of the systemic, mesenteric, celiac, and renal vascular beds; and the decrease in mesenteric O2 consumption seen after burns when LR alone is used for resuscitation. The HSD also moderated the systemic and mesenteric lipid peroxidation. Bacterial translocation was less in the HSD group (3 of 8 animals) compared with the LR group (5 of 8 animals), but was not statistically different. Hypertonic saline dextran may be beneficial in improving the postburn microcirculation and attenuating postburn oxidant-induced lipid peroxidation in the systemic tissues and the gut.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377286     DOI: 10.1097/00005373-199206000-00006

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  2 in total

1.  The effects of PAF antagonist on intestinal mucosal microcirculation after burn in rats.

Authors:  Pei-Wu Yu; Guang Xia Xiao; Li-Xin Zhou; Zi-Qiang Wang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Angiotensin II inhibitor DuP753 attenuates burn- and endotoxin-induced gut ischemia, lipid peroxidation, mucosal permeability, and bacterial translocation.

Authors:  T Tadros; D L Traber; J P Heggers; D N Herndon
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.